The Expression of Human Cytomegalovirus MicroRNA MIR-UL148D during Latent Infection in Primary Myeloid Cells Inhibits Activin A-triggered Secretion of IL-6

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Lau, Betty ^a   Poole, Emma ^a   Krishna, Benjamin ^a   Sellart, Immaculada ^a   Wills, Mark R ^a   Murphy, Eain ^b   Sinclair, John ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN; ACTIVIN A; ACTIVIN RECEPTOR 1; ACVR1B PROTEIN, HUMAN; CYTOKINE; IL6 PROTEIN, HUMAN; INTERLEUKIN 6; MICRORNA; MIR-UL-148D , HUMAN CYTOMEGALOVIRUS;

BONE MARROW CELL; CELL CULTURE; CYTOLOGY; CYTOMEGALOVIRUS; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; MONOCYTE; PHYSIOLOGY; UPREGULATION; VIROLOGY; VIRUS LATENCY;

ACTIVIN RECEPTORS, TYPE I; ACTIVINS; CELLS, CULTURED; CYTOKINES; CYTOMEGALOVIRUS; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-6; MICRORNAS; MONOCYTES; MYELOID CELLS; UP-REGULATION; VIRUS LATENCY;

EID: 84981216973     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep31205     Document Type: Article

References (83)

1. Sinclair, J. Human cytomegalovirus: Latency and reactivation in the myeloid lineage. J. Clin. Virol. 41, 180-185 (2008).
2. Reeves, M. B., Lehner, P. J., Sissons, J. G., Sinclair, J. H. An in vitro model for the regulation of human cytomegalovirus latency and reactivation in dendritic cells by chromatin remodelling. J. Gen. Virol. 86, 2949-2954 (2005).
3. Reeves, M. B., MacAry, P. A., Lehner, P. J., Sissons, J. G., Sinclair, J. H. Latency, chromatin remodeling, reactivation of human cytomegalovirus in the dendritic cells of healthy carriers. Proc. Natl. Acad. Sci. USA 102, 4140-4145 (2005).
4. Khaiboullina, S. F. et al. Human cytomegalovirus persists in myeloid progenitors and is passed to the myeloid progeny in a latent form. Br. J. Haematol. 126, 410-417 (2004).
5. Hahn, G., Jores, R., Mocarski, E. S. Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells. Proc. Natl. Acad. Sci. USA 95, 3937-3942 (1998).
6. Bolovan-Fritts, C. A., Mocarski, E. S., Wiedeman, J. A. Peripheral blood CD14(+ ) cells from healthy subjects carry a circular conformation of latent cytomegalovirus genome. Blood 93, 394-398 (1999).
7. Taylor-Wiedeman, J., Sissons, J. G., Borysiewicz, L. K., Sinclair, J. H. Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J. Gen. Virol. 72 (Pt 9), 2059-2064 (1991).
8. Poole, E., McGregor Dallas, S. R., Colston, J., Joseph, R. S., Sinclair, J. Virally induced changes in cellular microRNAs maintain latency of human cytomegalovirus in CD34(+ ) progenitors. J. Gen. Virol. 92, 1539-1549 (2011).
9. Poole, E., Wills, M., Sinclair, J. Human Cytomegalovirus Latency: Targeting Differences in the Latently Infected Cell with a View to Clearing Latent Infection. New Journal of Science 2014, 10 (2014).
10. Vicente, C., Conchillo, A., Garcia-Sanchez, M. A., Odero, M. D. The role of the GATA2 transcription factor in normal and malignant hematopoiesis. Crit. Rev. Oncol. Hematol. 82, 1-17 (2012).
11. Taylor-Wiedeman, J., Sissons, P., Sinclair, J. Induction of endogenous human cytomegalovirus gene expression after differentiation of monocytes from healthy carriers. J. Virol. 68, 1597-1604 (1994).
12. Soderberg-Naucler, C., Fish, K. N., Nelson, J. A. Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 91, 119-126 (1997).
13. Soderberg-Naucler, C. et al. Reactivation of latent human cytomegalovirus in CD14(+ ) monocytes is differentiation dependent. J. Virol. 75, 7543-7554 (2001).
14. Huang, M. M., Kew, V. G., Jestice, K., Wills, M. R., Reeves, M. B. Efficient human cytomegalovirus reactivation is maturation dependent in the Langerhans dendritic cell lineage and can be studied using a CD14+ experimental latency model. J. Virol. 86, 8507-8515 (2012).
15. Reeves, M. B., Sinclair, J. H. Circulating dendritic cells isolated from healthy seropositive donors are sites of human cytomegalovirus reactivation in vivo. J. Virol. 87, 10660-10667 (2013).
16. Hargett, D., Shenk, T. Experimental human cytomegalovirus latency in CD14+ monocytes. Proc. Natl. Acad. Sci. USA 107, 20039-20044 (2010).
17. Poole, E. et al. The myeloid transcription factor GATA-2 regulates the viral UL144 gene during human cytomegalovirus latency in an isolate-specific manner. J. Virol. 87, 4261-4271 (2013).
18. O'Connor, C. M., Murphy, E. A. A myeloid progenitor cell line capable of supporting human cytomegalovirus latency and reactivation, resulting in infectious progeny. J. Virol. 86, 9854-9865 (2012).
19. Van Damme, E. et al. Glucocorticosteroids trigger reactivation of human cytomegalovirus from latently infected myeloid cells and increase the risk for HCMV infection in D+ R+ liver transplant patients. J. Gen. Virol. 96, 131-143 (2015).
20. Goodrum, F., Jordan, C. T., Terhune, S. S., High, K., Shenk, T. Differential outcomes of human cytomegalovirus infection in primitive hematopoietic cell subpopulations. Blood 104, 687-695 (2004).
21. Slobedman, B. et al. Impact of human cytomegalovirus latent infection on myeloid progenitor cell gene expression. J. Virol. 78, 4054-4062 (2004).
22. Kondo, K., Kaneshima, H., Mocarski, E. S. Human cytomegalovirus latent infection of granulocyte-macrophage progenitors. Proc. Natl. Acad. Sci. USA 91, 11879-11883 (1994).
23. Rossetto, C. C., Tarrant-Elorza, M., Pari, G. S. Cis and trans acting factors involved in human cytomegalovirus experimental and natural latent infection of CD14 (+ ) monocytes and CD34 (+ ) cells. PLoS Pathog. 9, e1003366 (2013).
24. Shen, Z. Z. et al. Comprehensive analysis of human cytomegalovirus microRNA expression during lytic and quiescent infection. PLoS One 9, e88531 (2014).
25. Fu, M. et al. Human cytomegalovirus latent infection alters the expression of cellular and viral microRNA. Gene 536, 272-278 (2014).
26. Meshesha, M. K., Bentwich, Z., Solomon, S. A., Avni, Y. S. In vivo expression of human cytomegalovirus (HCMV) microRNAs during latency. Gene 575, 101-107 (2016).
27. Zhu, Y., Haecker, I., Yang, Y., Gao, S. J., Renne, R. gamma-Herpesvirus-encoded miRNAs and their roles in viral biology and pathogenesis. Curr. Opin. Virol. 3, 266-275 (2013).
28. Tirabassi, R. et al. Human Cytomegalovirus US7 is Regulated Synergistically by Two Virally-Encoded miRNAs and by Two Distinct Mechanisms. J. Virol. 85, 11938-11944 (2011).
29. Stark, T. J., Arnold, J. D., Spector, D. H., Yeo, G. W. High-resolution profiling and analysis of viral and host small RNAs during human cytomegalovirus infection. J. Virol. 86, 226-235 (2012).
30. Meshesha, M. K. et al. The microRNA Transcriptome of Human Cytomegalovirus (HCMV). Open Virol. J. 6, 38-48 (2012).
31. Feldman, E. R. et al. Virus-encoded microRNAs facilitate gammaherpesvirus latency and pathogenesis in vivo. mBio 5, e00981-00914 (2014).
32. Forte, E., Luftig, M. A. The role of microRNAs in Epstein-Barr virus latency and lytic reactivation. Microbes Infect. 13, 1156-1167 (2011).
33. Gupta, A., Gartner, J. J., Sethupathy, P., Hatzigeorgiou, A. G., Fraser, N. W. Anti-apoptotic function of a microRNA encoded by the HSV-1 latency-associated transcript. Nature 442, 82-85 (2006).
34. Tang, S., Patel, A., Krause, P. R. Novel less-abundant viral microRNAs encoded by herpes simplex virus 2 latency-associated transcript and their roles in regulating ICP34.5 and ICP0 mRNAs. J. Immunol. 83, 1433-1442 (2009).
35. Umbach, J. L. et al. MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate viral mRNAs. Nature 454, 780-783 (2008).
36. Grey, F. et al. Identification and characterization of human cytomegalovirus-encoded microRNAs. J. Virol. 79, 12095-12099 (2005).
37. Kim, Y. et al. Human cytomegalovirus clinical strain-specific microRNA miR-UL148D targets the human chemokine RANTES during infection. PLoS Pathog. 8, e1002577 (2012).
38. Schmittgen, T. D., Livak, K. J. Analyzing real-time PCR data by the comparative CT method. Nat. Protoc. 3, 1101-1108 (2008).
39. Griffiths-Jones, S., Grocock, R. J., van Dongen, S., Bateman, A., Enright, A. J. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res. 34, D140-144 (2006).
40. Wang, F. Z. et al. Human cytomegalovirus infection alters the expression of cellular microRNA species that affect its replication. J. Virol. 82, 9065-9074 (2008).
41. Weekes, M. P. et al. Latency-associated degradation of the MRP1 drug transporter during latent human cytomegalovirus infection. Science 340, 199-202 (2013).
42. Straschewski, S. et al. Human cytomegaloviruses expressing yellow fluorescent fusion proteins-characterization and use in antiviral screening. PLoS One 5, e9174 (2010).
43. Sarcinella, E., Brown, M., Tellier, R., Petric, M., Mazzulli, T. Detection of RNA in purified cytomegalovirus virions. Virus Res. 104, 129-137 (2004).
44. Greijer, A. E., Dekkers, C. A., Middeldorp, J. M. Human cytomegalovirus virions differentially incorporate viral and host cell RNA during the assembly process. J. Virol. 74, 9078-9082 (2000).
45. Terhune, S. S., Schroer, J., Shenk, T. RNAs are packaged into human cytomegalovirus virions in proportion to their intracellular concentration. J. Virol. 78, 10390-10398 (2004).
46. Stern-Ginossar, N. et al. Analysis of human cytomegalovirus-encoded microRNA activity during infection. J. Virol. 83, 10684-10693 (2009).
47. Dunn, W. et al. Human cytomegalovirus expresses novel microRNAs during productive viral infection. Cell. Microbiol. 7, 1684-1695 (2005).
48. Pfeffer, S. et al. Identification of microRNAs of the herpesvirus family. Nat. Methods 2, 269-276 (2005).
49. Pavelin, J. et al. Systematic microRNA analysis identifies ATP6V0C as an essential host factor for human cytomegalovirus replication. PLoS Pathog. 9, e1003820 (2013).
50. Wang, Y. P. et al. Identification of immediate early gene X-1 as a cellular target gene of hcmv-mir-UL148D. Int. J. Mol. Med. 31, 959-966 (2013).
51. Kruger, J., Rehmsmeier, M. RNAhybrid: microRNA target prediction easy, fast and flexible. Nucleic Acids Res. 34, W451-454 (2006).
52. Elefant, N. et al. RepTar: a database of predicted cellular targets of host and viral miRNAs. Nucleic Acids Res. 39, D188-194 (2011).
53. Grey, F., Meyers, H., White, E. A., Spector, D. H., Nelson, J. A human cytomegalovirus-encoded microRNA regulates expression of multiple viral genes involved in replication. PLoS Pathog. 3, e163 (2007).
54. Stern-Ginossar, N. et al. Host immune system gene targeting by a viral miRNA. Science 317, 376-381 (2007).
55. Loomans, H. A.,l, C. D. Intertwining of Activin A and TGFbeta Signaling: Dual Roles in Cancer Progression and Cancer Cell Invasion. Cancers 7, 70-91 (2014).
56. Sozzani, S., Musso, T. The yin and yang of Activin A. Blood 117, 5013-5015 (2011).
57. Yamashita, N. et al. Effects of activin A on IgE synthesis and cytokine production by human peripheral mononuclear cells. Clin. Exp. Immunol. 94, 214-219 (1993).
58. Ohguchi, M. et al. Activin A regulates the production of mature interleukin-1beta and interleukin-1 receptor antagonist in human monocytic cells. J. Interferon Cytokine Res. 18, 491-498 (1998).
59. Salogni, L. et al. Activin A induces dendritic cell migration through the polarized release of CXC chemokine ligands 12 and 14. Blood 113, 5848-5856 (2009).
60. Musso, T. et al. Activin A induces Langerhans cell differentiation in vitro and in human skin explants. PLoS One 3, e3271 (2008).
61. Sierra-Filardi, E. et al. Activin A skews macrophage polarization by promoting a proinflammatory phenotype and inhibiting the acquisition of anti-inflammatory macrophage markers. Blood 117, 5092-5101 (2011).
62. Escribese, M. M. et al. The prolyl hydroxylase PHD3 identifies proinflammatory macrophages and its expression is regulated by activin A. J. Immunol. 189, 1946-1954 (2012).
63. Segerer, S. E. et al. The glycoprotein-hormones activin A and inhibin A interfere with dendritic cell maturation. Reprod. Biol. Endocrinol. 6, 17 (2008).
64. Maussang, D. et al. Human cytomegalovirus-encoded chemokine receptor US28 promotes tumorigenesis. Proc. Natl. Acad. Sci. USA 103, 13068-13073 (2006).
65. Robson, N. C. et al. Activin-A: a novel dendritic cell-derived cytokine that potently attenuates CD40 ligand-specific cytokine and chemokine production. Blood 111, 2733-2743 (2008).
66. Reeves, M. B., Compton, T. Inhibition of inflammatory Interleukin-6 activity via ERK-MAPK Signaling Antagonizes Human Cytomegalovirus Reactivation from Dendritic Cells from Latency. J. Virol. 85, 12750-12758 (2011).
67. Dölken, L., Pfeffer, S., Koszinowski, U. H. Cytomegalovirus microRNAs. Virus Genes 38, 355-364 (2009).
68. Mason, G. M. et al. Human cytomegalovirus latency-associated proteins elicit immune-suppressive IL-10 producing CD4(+ ) T cells. PLoS Pathog. 9, e1003635 (2013).
69. Lin, G. et al. Interleukin-6 inhibits regulatory T cells and improves the proliferation and cytotoxic activity of cytokine-induced killer cells. J. Immunother. 35, 337-343 (2012).
70. Nish, S. A. et al. T cell-intrinsic role of IL-6 signaling in primary and memory responses. eLife 3, e01949 (2014).
71. Takeda, K. et al. Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: generation and characterization of T cell-specific Stat3-deficient mice. J. Immunol. 161, 4652-4660 (1998).
72. Luger, T. A. et al. IFN-beta 2/IL-6 augments the activity of human natural killer cells. J. Immunol. 143, 1206-1209 (1989).
73. Gazit, R. et al. Expression of KIR2DL1 on the entire NK cell population: a possible novel immunodeficiency syndrome. Blood 103, 1965-1966 (2004).
74. Jackson, S. E., Mason, G. M., Wills, M. R. Human cytomegalovirus immunity and immune evasion. Virus Res. 157, 151-160 (2011).
75. Hook, L. M. et al. Cytomegalovirus miRNAs target secretory pathway genes to facilitate formation of the virion assembly compartment and reduce cytokine secretion. Cell Host Microbe 15, 363-373 (2014).
76. Duan, F., Liao, J., Huang, Q., Nie, Y., Wu, K. HSV-1 miR-H6 inhibits HSV-1 replication and IL-6 expression in human corneal epithelial cells in vitro. Clin. Dev. Immunol. 2012, 192791 (2012).
77. Waller, E. C., Day, E., Sissons, J. G., Wills, M. R. Dynamics of T cell memory in human cytomegalovirus infection. Med. Microbiol. Immunol. 197, 83-96 (2008).
78. Sinzger, C. et al. Cloning and sequencing of a highly productive, endotheliotropic virus strain derived from human cytomegalovirus TB40/E. J. Gen. Virol. 89, 359-368 (2008).
79. Lee, S. H. et al. BclAF1 restriction factor is neutralized by proteasomal degradation and microRNA repression during human cytomegalovirus infection. Proc. Natl. Acad. Sci. USA 109, 9575-9580 (2012).
80. Poole, E. et al. Latency-associated viral interleukin-10 (IL-10) encoded by human cytomegalovirus modulates cellular IL-10 and CCL8 Secretion during latent infection through changes in the cellular microRNA hsa-miR-92a. J. Virol. 88, 13947-13955 (2014).
81. Liang, W., Mason, A. J., Lam, J. K. Western blot evaluation of siRNA delivery by pH-responsive peptides. Methods Mol. Biol. 986, 73-87 (2013).
82. Cuschieri, J., Bulger, E., Grinsell, R., Garcia, I., Maier, R. V. Insulin regulates macrophage activation through activin A. Shock 29, 285-290 (2008).
83. Aleman-Muench, G. R., Soldevila, G. When versatility matters: activins/inhibins as key regulators of immunity. Immunol. Cell Biol. 90, 137-148 (2012).